Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Clinical and Translational Radiation Oncology
|
March 17, 2025
Recovery of quality of life in 574 patients with inoperable lung cancer undergoing (chemo)radiotherapy
Marloes Nies, Robin Wijsman, Olga Chouvalova, et al.
Medical Physics
|
June 24, 2020
Investigation of inter-fraction target motion variations in the context of pencil beam scanned proton therapy in non-small cell lung cancer patients
Lydia A den Otter, Renske M Anakotta, Menkedina Weessies, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 28, 2026
Pretreatment risk model for radiation-induced lymphopenia is associated with adjuvant durvalumab efficacy in patients with unresectable stage III NSCLC
Peter S N van Rossum, Pim J J Damen, Francesco Cortiula, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 23, 2018
External validation of an NTCP model for acute esophageal toxicity in locally advanced NSCLC patients treated with intensity-modulated (chemo-)radiotherapy
Frank J W M Dankers, Robin Wijsman, Esther G C Troost, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 31, 2016
Development of symptomatic brain metastases after chemoradiotherapy for stage III non-small cell lung cancer: Does the type of chemotherapy regimen matter?
Lizza E L Hendriks, -Anita J W M Brouns, Mohammad Amini, et al.
Acta Oncologica (Stockholm, Sweden)
|
February 13, 2025
Rising incidence of radiation pneumonitis after adjuvant durvalumab in NSCLC patients treated with concurrent chemoradiotherapy
Rutger H Stoffers, Anne G H Niezink, Olga Chouvalova, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 24, 2023
Proton and photon radiotherapy in stage III NSCLC: Effects on hematological toxicity and adjuvant immune therapy
Francesco Cortiula, Lizza E L Hendriks, Robin Wijsman, et al.
Cancers
|
July 27, 2024
Baseline Blood CD8<sup>+</sup> T Cell Activation Potency Discriminates Responders from Non-Responders to Immune Checkpoint Inhibition Combined with Stereotactic Radiotherapy in Non-Small-Cell Lung Cancer
Hanneke Kievit, M Benthe Muntinghe-Wagenaar, Wayel H Abdulahad, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 16, 2023
External validation of NTCP-models for radiation pneumonitis in lung cancer patients treated with chemoradiotherapy
Anne G H Niezink, Arjen van der Schaaf, Robin Wijsman, et al.
Medical Physics
|
May 16, 2018
Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers
Timo M Deist, Frank J W M Dankers, Gilmer Valdes, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Clinical and Translational Radiation Oncology
|
March 17, 2025
Recovery of quality of life in 574 patients with inoperable lung cancer undergoing (chemo)radiotherapy
Marloes Nies, Robin Wijsman, Olga Chouvalova, et al.
Medical Physics
|
June 24, 2020
Investigation of inter-fraction target motion variations in the context of pencil beam scanned proton therapy in non-small cell lung cancer patients
Lydia A den Otter, Renske M Anakotta, Menkedina Weessies, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 28, 2026
Pretreatment risk model for radiation-induced lymphopenia is associated with adjuvant durvalumab efficacy in patients with unresectable stage III NSCLC
Peter S N van Rossum, Pim J J Damen, Francesco Cortiula, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 23, 2018
External validation of an NTCP model for acute esophageal toxicity in locally advanced NSCLC patients treated with intensity-modulated (chemo-)radiotherapy
Frank J W M Dankers, Robin Wijsman, Esther G C Troost, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 31, 2016
Development of symptomatic brain metastases after chemoradiotherapy for stage III non-small cell lung cancer: Does the type of chemotherapy regimen matter?
Lizza E L Hendriks, -Anita J W M Brouns, Mohammad Amini, et al.
Acta Oncologica (Stockholm, Sweden)
|
February 13, 2025
Rising incidence of radiation pneumonitis after adjuvant durvalumab in NSCLC patients treated with concurrent chemoradiotherapy
Rutger H Stoffers, Anne G H Niezink, Olga Chouvalova, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 24, 2023
Proton and photon radiotherapy in stage III NSCLC: Effects on hematological toxicity and adjuvant immune therapy
Francesco Cortiula, Lizza E L Hendriks, Robin Wijsman, et al.
Cancers
|
July 27, 2024
Baseline Blood CD8<sup>+</sup> T Cell Activation Potency Discriminates Responders from Non-Responders to Immune Checkpoint Inhibition Combined with Stereotactic Radiotherapy in Non-Small-Cell Lung Cancer
Hanneke Kievit, M Benthe Muntinghe-Wagenaar, Wayel H Abdulahad, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 16, 2023
External validation of NTCP-models for radiation pneumonitis in lung cancer patients treated with chemoradiotherapy
Anne G H Niezink, Arjen van der Schaaf, Robin Wijsman, et al.
Medical Physics
|
May 16, 2018
Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers
Timo M Deist, Frank J W M Dankers, Gilmer Valdes, et al.
Page
of 5